Core Scientific Inc (CORZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,065,392 | 311,378 | 453,443 | 581,345 | 698,725 |
| Receivables | N/A | N/A | N/A | N/A | 1,018 |
| Other current assets | 389,440 | 584,159 | 607,590 | 423,415 | 80,646 |
| TOTAL | $1,454,832 | $895,537 | $1,061,033 | $1,004,760 | $833,178 |
| Non-Current Assets | |||||
| PPE Net | 1,344,924 | 1,293,299 | 1,078,803 | 828,603 | 650,291 |
| Other Non-Current Assets | 269,808 | 158,808 | 156,144 | 144,689 | 141,902 |
| TOTAL | $1,614,732 | $1,452,107 | $1,234,947 | $973,292 | $792,193 |
| Total Assets | $3,069,564 | $2,347,644 | $2,295,980 | $1,978,052 | $1,625,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 218,857 | 126,106 | 212,179 | 215,055 | 6,328 |
| Accrued Expenses | 364,479 | 511,957 | 358,270 | 180,641 | 95,492 |
| Other current liabilities | 864,948 | 15,777 | 15,675 | 16,899 | 5,461 |
| TOTAL | $2,661,783 | $781,401 | $669,863 | $562,722 | $195,510 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 219,555 | 127,561 | 83,739 | 150,127 | 60,872 |
| Other Non-Current Liabilities | 1,278,795 | 2,100,693 | 2,754,077 | 2,480,006 | 1,611,368 |
| TOTAL | $1,713,467 | $2,528,983 | $2,754,077 | $2,480,006 | $1,611,368 |
| Total Liabilities | $4,375,250 | $3,310,384 | $3,423,940 | $3,042,728 | $1,806,878 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 317,885 | 315,333 | 310,061 | 305,408 | 297,822 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -4,493,891 | -4,146,703 | -4,237,984 | -4,091,324 | -3,154,525 |
| TOTAL | $-1,305,686 | $-962,740 | $-1,127,960 | $-1,064,676 | $-181,507 |
| Total Liabilities And Equity | $3,069,564 | $2,347,644 | $2,295,980 | $1,978,052 | $1,625,371 |